Skip to product information
1 of 1
IHC of Renal Cell Carcinoma on a FFPE Kidney Tissue
Home Product Renal Cell Carcinoma

Renal Cell Carcinoma (PN-15)

US
IVD-CE
Europe
IVD-CE
International
IVD-CE
Size
Contact for price View full details

Product Information

Summary & Explanation

{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"Renal Cell Carcinoma, also known as a Gurnistical Tumor, is the most common form of kidney cancer arising from the renal tubule. It is also the most common type of kidney cancer in adults. Initial treatment is surgery because it is notoriously resistant to radiation therapy and chemotherapy, although some cases respond to\n immunotherapy."}]},{"type":"paragraph","children":[{"type":"text","value":"Renal Cell Carcinoma antibody recognizes a 200 kDa glycoprotein localized in the brush border of the proximal renal tubule. This antibody immunoreacts with approximately 90% of Primary Renal Cell Carcinomas and approximately 85% of Metastatic Renal Cell Carcinomas. Other tumors that may react with this antibody\n are Parathyroid Adenoma, an occasional Breast Carcinoma. Nephroblastoma, Oncocytoma, Mesoblastic Nephroma, Transitional Cell Carcinoma, and Angiomyolipoma are not labeled with this antibody."}]}]}

Antibody Type

Mouse Monoclonal

Clone

PN-15

Isotype

IgG1/K

Localization

Cytoplasmic, Membranous

Dilution

1:50-1:200

Species Reactivity

Human, Rat

Immunogen

Microsomal fraction of human renal cortical tissue homogenate.